1-8 of 8
Stefan O Schoenland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Michel van Gelder, MD PhD, Dimitris Ziagkos, Liesbeth C de Wreede, PhD, Anja van Biezen, Peter Dreger, MD, Martin Gramatzki, MD, Matthias Stelljes, Niels Smedegaard Andersen, Nicolaas PM Schaap, MD, Antonin Vitek, Dietrich Beelen, MD, Liisa Volin, MD PhD, Jürgen Finke, Jakob R Passweg, MD, Arnold Ganser, Maciej J Machaczka, MD, Julio Delgado, MD, William Krüger, Edgar Faber, Gerard Socie, Pavel Jindra, MD PhD, Boris V Afanasyev, Professor, Matthias Theobald, MD PhD, Yves Chalandon, MD, Anja Henseler, Stefan O. Schoenland, MD, Kroger Nicolaus, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 522.
https://doi.org/10.1182/blood.V128.22.522.522
Published: 2016
Journal Articles

HOVON 104; Results of First 25 Patients from a Multicenter, Multinational, Prospective Phase II Study of Bortezomib Based Induction Treatment Followed By Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Al Amyloidosis

Monique Minnema, Kazem Nasserinejad, MA, Bouke Hazenberg, MD PhD, Ute Hegenbart, Lucien Noens, MD PhD, Paula F. Ypma, MD, Sonja Zweegman, MD PhD, Lidwine Winnifred Tick, MD PhD, Annemiek Broijl, MD PhD, Harry R. Koene, MD PhD, Gerard M.J. Bos, MD PhD, Pieter Sonneveld, MD PhD, Stefan O. Schoenland, MD
Journal: Blood
Blood (2016) 128 (22): 4628.
https://doi.org/10.1182/blood.V128.22.4628.4628
Published: 2016
Journal Articles

Long-Term Outcome of a Phase 1 Study of the Investigational Oral Proteasome Inhibitor (PI) Ixazomib at the Recommended Phase 3 Dose (RP3D) in Patients (Pts) with Relapsed or Refractory Systemic Light-Chain (AL) Amyloidosis (RRAL)

Giampaolo Merlini, MD, Vaishali Sanchorawala, MD, Zonder A Jeffrey, MD, Vishal Kukreti, MD FRCPC, Stefan O Schoenland, MD, Arnaud Jaccard, MD, Angela Dispenzieri, MD, Adam D. Cohen, MD, Deborah Berg, RN, MSN, Zheng Yuan, PhD, Ai-Min Hui, MD PhD, Palladini Giovanni, MD PhD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2014) 124 (21): 3450.
https://doi.org/10.1182/blood.V124.21.3450.3450
Published: 2014
Journal Articles

Shift to a New Donor Does Not Improve the Outcome After Second Allogeneic Stem Cell Transplantation (alloSCT) in Acute Leukemia Relapse After a First Allosct – a Risk Factor Analysis by the German Stem Cell Registry (DRST).

Maximilian Christopeit, MD, Ulrike Feldmann, Juergen Finke, Donald W. Bunjes, MD, PhD, Dietrich W. Beelen, Martin Bornhaeuser, Christoph Faul, MD, Rainer Schwerdtfeger, MD, Hans-Jochem Kolb, MD, Martin Gramatzki, Hans Martin, MD, Stefan O Schoenland, Christof Scheid, Lutz Uharek, Axel R. Zander, Arnold Ganser, MD, Guido Kobbe, MD, Ernst Holler, PhD, Axel A Fauser, Joachim Kienast, Hermann Einsele, Herbert G. Sayer, MD, PhD, Ralph Mayer, MD, Gerhard Behre, MD, Hellmut Ottinger, Hubert Schrezenmeier, Christoph Schmid
Journal: Blood
Blood (2009) 114 (22): 3328.
https://doi.org/10.1182/blood.V114.22.3328.3328
Published: 2009
Journal Articles

Improvement of Long-Term Survival after High-Dose Melphalan in Patients with Light Chain Amyloidosis Responding to Induction Chemotherapy.

Anja Mangatter, Stefan O Schoenland, Marion Hansberg, Tilmann Bochtler, Sascha Dietrich, Peter Dreger, Kai Neben, Anthony Ho, Hartmut Goldschmidt, Ute Hegenbart
Journal: Blood
Blood (2008) 112 (11): 3334.
https://doi.org/10.1182/blood.V112.11.3334.3334
Published: 2008
Journal Articles

Evaluation of Safety and Efficacy of Different Stem Cell Mobilization Regimens in 110 Patients with Light Chain Amyloidosis

Marion Hansberg, Stefan O Schoenland, Anja Mangatter, Sascha Dietrich, Peter Dreger, MD, Kai Neben, Anthony Ho, Hartmut Goldschmidt, Ute Hegenbart
Journal: Blood
Blood (2008) 112 (11): 3709.
https://doi.org/10.1182/blood.V112.11.3709.3709
Published: 2008
Journal Articles

Single Center Experience of Lenalidomide/Dexamethasone Treatment in 40 Patients with Light Chain Amyloidosis: High Toxicity in Patients with Severe Impaired Renal and Cardiac Function.

Stefan O Schoenland, Tilmann Bochtler, Sascha Dietrich, Ulrike Klein, Hartmut Goldschmidt, Anthony Ho, Ute Hegenbart
Journal: Blood
Blood (2008) 112 (11): 1736.
https://doi.org/10.1182/blood.V112.11.1736.1736
Published: 2008
Journal Articles

Allogeneic and Syngeneic Hematopoietic Cell Transplants in Patients with AL-Amyloidosis: A Report from the European Group for Blood and Marrow Transplantation (EBMT).

Stefan O. Schoenland, M.D., Michel Baccarani, M.D., Andrew Campbell, M.D., Enric Carreras, M.D., Catherine Cordonnier, M.D., Leanthe Grommisch, M.D., Veronique Leblond, M.D., Timothy J. Littlewood, M.D., Leo F. Verdonck, M.D., L. Wood, M.D., Pierre Zachee, M.D., Axel R. Zander, M.D., Hartmut Goldschmidt, M.D., Dietger Niederwieser, M.D., Goesta Gahrton, M.D.
Journal: Blood
Blood (2004) 104 (11): 5133.
https://doi.org/10.1182/blood.V104.11.5133.5133
Published: 2004